Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 8.32% is in line with its 5-year average of 7.83%, near the high end of its 5-year range (4.63%–9.26%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.18% above its 12-month average of 8.14%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 8.32%.
RETURN ON INVESTED CAPITAL (ROIC)
8.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
8.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
8.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
7.83%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
5.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.18%
CURRENT VS 3Y AVG
-0.49%
CURRENT VS 5Y AVG
+6.18%
CURRENT VS 10Y AVG
+51.94%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.75%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-4.91%
vs the sector median at left
IQVIA Holdings Inc.
Market Cap
$44.25B
Return on Invested Capital (ROIC)
8.32%
TTM Avg
8.14%
3Y Avg
8.36%
5Y Avg
7.83%
Market Cap
$44.87B
Return on Invested Capital (ROIC)
6.79%
TTM Avg
3.17%
3Y Avg
0.33%
5Y Avg
-0.73%
Market Cap
$43.41B
Return on Invested Capital (ROIC)
11.88%
TTM Avg
12.59%
3Y Avg
13.58%
5Y Avg
12.74%
Market Cap
$46.18B
Return on Invested Capital (ROIC)
4.52%
TTM Avg
3.25%
3Y Avg
5.37%
5Y Avg
7.01%
Market Cap
$40.52B
Return on Invested Capital (ROIC)
41.33%
TTM Avg
37.21%
3Y Avg
35.10%
5Y Avg
36.21%
Market Cap
$50.11B
Return on Invested Capital (ROIC)
3.72%
TTM Avg
4.38%
3Y Avg
4.32%
5Y Avg
3.88%
Market Cap
$51.41B
Return on Invested Capital (ROIC)
10.22%
TTM Avg
11.08%
3Y Avg
14.46%
5Y Avg
15.87%
Market Cap
$54.46B
Return on Invested Capital (ROIC)
13.45%
TTM Avg
12.41%
3Y Avg
9.39%
5Y Avg
5.98%
Market Cap
$33.11B
Return on Invested Capital (ROIC)
19.18%
TTM Avg
19.41%
3Y Avg
18.01%
5Y Avg
17.23%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IQVIA Holdings Inc. (IQV) | $44.25B | 8.32% | 8.14% | 8.36% | 7.83% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $44.87B | 6.79% | 3.17% | 0.33% | -0.73% |
| Agilent Technologies, Inc. (A)vs › | $43.41B | 11.88% | 12.59% | 13.58% | 12.74% |
| Humana Inc. (HUM)vs › | $46.18B | 4.52% | 3.25% | 5.37% | 7.01% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.52B | 41.33% | 37.21% | 35.10% | 36.21% |
| Becton, Dickinson and Company (BDX)vs › | $50.11B | 3.72% | 4.38% | 4.32% | 3.88% |
| Edwards Lifesciences Corporation (EW)vs › | $51.41B | 10.22% | 11.08% | 14.46% | 15.87% |
| Cardinal Health, Inc. (CAH)vs › | $54.46B | 13.45% | 12.41% | 9.39% | 5.98% |
| ResMed Inc. (RMD)vs › | $33.11B | 19.18% | 19.41% | 18.01% | 17.23% |
| DexCom, Inc. (DXCM)vs › | $32.96B | 21.71% | 13.47% | 11.13% | 9.67% |
ROIC
8.3%
ROE
22.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 8.32% |
| 2026-03-31 | 8.42% |
| 2025-12-31 | 8.23% |
| 2025-09-30 | 7.87% |
| 2025-06-30 | 7.86% |
| 2025-03-31 | 8.42% |
| 2024-12-31 | 8.67% |
| 2024-09-30 | 9.26% |
| 2024-06-30 | 9.25% |
| 2024-03-31 | 9.12% |
| 2023-12-31 | 8.80% |
| 2023-09-30 | 7.32% |
| 2023-06-30 | 7.11% |
| 2023-03-31 | 7.03% |
| 2022-12-31 | 7.36% |
| 2022-09-30 | 8.10% |
| 2022-06-30 | 7.52% |
| 2022-03-31 | 6.63% |
| 2021-12-31 | 6.14% |
| 2021-09-30 | 5.22% |
| 2021-06-30 | 4.63% |
| 2021-03-31 | 3.71% |
| 2020-12-31 | 3.02% |
| 2020-09-30 | 2.28% |
| 2020-06-30 | 2.28% |
| 2020-03-31 | 2.96% |
| 2019-12-31 | 2.72% |
| 2019-09-30 | 3.39% |
| 2019-06-30 | 3.28% |
| 2019-03-31 | 3.02% |
| 2018-12-31 | 3.21% |
| 2018-09-30 | 3.83% |
| 2018-06-30 | 3.85% |
| 2018-03-31 | 3.64% |
| 2017-12-31 | 3.61% |
| 2017-09-30 | 1.84% |
| 2017-06-30 | 1.81% |
| 2017-03-31 | 1.86% |
| 2016-12-31 | 1.90% |
| 2016-09-30 | 18.75% |
| 2016-06-30 | 19.80% |
| 2016-03-31 | 19.68% |
| 2015-12-31 | 19.10% |
| 2015-09-30 | 17.50% |
| 2015-06-30 | 21.11% |
| 2015-03-31 | 21.67% |
| 2014-12-31 | 22.56% |
| 2014-09-30 | 23.14% |
| 2014-06-30 | 23.08% |
| 2014-03-31 | 20.74% |
| 2013-12-31 | 20.39% |
| 2013-09-30 | 19.41% |
| 2013-06-30 | 19.92% |
| 2013-03-31 | 21.78% |
| 2012-12-31 | 20.86% |
